creatine has been researched along with Adenocarcinoma in 15 studies
Adenocarcinoma: A malignant epithelial tumor with a glandular organization.
| Excerpt | Relevance | Reference |
|---|---|---|
| " After a first cycle of cisplatin and pemetrexed, he had unusually prolonged aplasia and acute kidney injury." | 7.85 | Unusually prolonged pemetrexed cytotoxicity in a patient with a lung adenocarcinoma: a case report. ( Moro-Sibilot, D; Pinsolle, J; Pluchart, H; Sakhri, L, 2017) |
| " After a first cycle of cisplatin and pemetrexed, he had unusually prolonged aplasia and acute kidney injury." | 3.85 | Unusually prolonged pemetrexed cytotoxicity in a patient with a lung adenocarcinoma: a case report. ( Moro-Sibilot, D; Pinsolle, J; Pluchart, H; Sakhri, L, 2017) |
| "The histologic diagnosis was squamous cell carcinoma in four cases and adenocarcinoma in three." | 1.33 | Pulmonary resection for non-small-cell lung cancer in patients on hemodialysis: clinical outcome and long-term results. ( Augello, G; Carretta, A; Casiraghi, M; Ciriaco, P; Libretti, L; Melloni, G; Zannini, P, 2005) |
| "An estimate of the spatial extent of prostate cancer was determined by generating metabolite images in which this metabolite ratio significantly exceeded normal peripheral zone values in multiple contiguous sections." | 1.29 | Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution. ( Carroll, P; Hricak, H; Kurhanewicz, J; Narayan, P; Nelson, SJ; Vigneron, DB, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (20.00) | 18.7374 |
| 1990's | 7 (46.67) | 18.2507 |
| 2000's | 2 (13.33) | 29.6817 |
| 2010's | 3 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sakhri, L | 1 |
| Pinsolle, J | 1 |
| Moro-Sibilot, D | 1 |
| Pluchart, H | 1 |
| An, YJ | 1 |
| Cho, HR | 1 |
| Kim, TM | 1 |
| Keam, B | 1 |
| Kim, JW | 1 |
| Wen, H | 1 |
| Park, CK | 1 |
| Lee, SH | 1 |
| Im, SA | 1 |
| Kim, JE | 1 |
| Choi, SH | 1 |
| Park, S | 1 |
| García-Martín, ML | 1 |
| Adrados, M | 1 |
| Ortega, MP | 1 |
| Fernández González, I | 1 |
| López-Larrubia, P | 1 |
| Viaño, J | 1 |
| García-Segura, JM | 1 |
| WATKIN, DM | 1 |
| STEINFELD, JL | 1 |
| Ciriaco, P | 1 |
| Casiraghi, M | 1 |
| Melloni, G | 1 |
| Carretta, A | 1 |
| Libretti, L | 1 |
| Augello, G | 1 |
| Zannini, P | 1 |
| Patra, S | 1 |
| Bera, S | 1 |
| SinhaRoy, S | 1 |
| Ghoshal, S | 1 |
| Ray, S | 1 |
| Basu, A | 1 |
| Schlattner, U | 1 |
| Wallimann, T | 1 |
| Ray, M | 1 |
| Kurhanewicz, J | 1 |
| Vigneron, DB | 1 |
| Hricak, H | 1 |
| Narayan, P | 1 |
| Carroll, P | 1 |
| Nelson, SJ | 1 |
| Bergnes, G | 1 |
| Yuan, W | 1 |
| Khandekar, VS | 1 |
| O'Keefe, MM | 1 |
| Martin, KJ | 1 |
| Teicher, BA | 1 |
| Kaddurah-Daouk, R | 1 |
| Nakai, T | 1 |
| Ishima, R | 1 |
| Sakahara, H | 1 |
| Endo, K | 1 |
| Konishi, J | 1 |
| Akasaka, K | 1 |
| Burtscher, IM | 1 |
| Ståhlberg, F | 1 |
| Holtås, S | 1 |
| Lee, JH | 1 |
| Cho, KS | 1 |
| Kim, YM | 1 |
| Kim, ST | 1 |
| Mun, CW | 1 |
| Na, JH | 1 |
| Mok, JE | 1 |
| Lim, TH | 1 |
| Kristensen, CA | 1 |
| Askenasy, N | 1 |
| Jain, RK | 1 |
| Koretsky, AP | 1 |
| Stubbs, M | 2 |
| Rodrigues, LM | 2 |
| Gusterson, BA | 1 |
| Griffiths, JR | 2 |
| Tucci, JR | 1 |
| Jagger, PI | 1 |
| Lauler, DP | 1 |
| Thorn, GW | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Trans-Rectal Placement of Prostatic Fiducial Markers Under MR-Guidance in Patients Receiving External Beam Radiotherapy for Prostate Cancer: A Pilot Study[NCT00061347] | Phase 1 | 15 participants (Actual) | Interventional | 2003-05-23 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for creatine and Adenocarcinoma
| Article | Year |
|---|---|
Rapid dexamethasone suppression test for Cushing's syndrome.
Topics: 17-Ketosteroids; Adenocarcinoma; Adolescent; Adrenal Gland Diseases; Adrenal Gland Neoplasms; Adreno | 1967 |
14 other studies available for creatine and Adenocarcinoma
| Article | Year |
|---|---|
Unusually prolonged pemetrexed cytotoxicity in a patient with a lung adenocarcinoma: a case report.
Topics: Acute Kidney Injury; Adenocarcinoma; Adenocarcinoma of Lung; Antineoplastic Agents; Antineoplastic C | 2017 |
An NMR metabolomics approach for the diagnosis of leptomeningeal carcinomatosis in lung adenocarcinoma cancer patients.
Topics: Adenocarcinoma; Alanine; Area Under Curve; Biomarkers, Tumor; Case-Control Studies; Citric Acid; Cre | 2015 |
Quantitative (1) H MR spectroscopic imaging of the prostate gland using LCModel and a dedicated basis-set: correlation with histologic findings.
Topics: Adenocarcinoma; Choline; Citric Acid; Creatine; Humans; In Vitro Techniques; Magnetic Resonance Spec | 2011 |
METABOLIC RELATIONSHIPS BETWEEN TUMOR AND HOST DURING MASSIVE DOSES OF PREDNISONE IN HUMAN NEOPLASTIC DISEASE.
Topics: 17-Ketosteroids; Adenocarcinoma; Biomedical Research; Blood; Calcium; Chlorides; Creatine; Creatinin | 1964 |
Pulmonary resection for non-small-cell lung cancer in patients on hemodialysis: clinical outcome and long-term results.
Topics: Adenocarcinoma; Adult; Aged; Blood Urea Nitrogen; Carcinoma, Squamous Cell; Contraindications; Creat | 2005 |
Progressive decrease of phosphocreatine, creatine and creatine kinase in skeletal muscle upon transformation to sarcoma.
Topics: Adenocarcinoma; Animals; Cell Transformation, Neoplastic; Colorectal Neoplasms; Creatine; Creatine K | 2008 |
Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution.
Topics: Adenocarcinoma; Adult; Aged; Choline; Citrates; Citric Acid; Creatine; Diagnosis, Differential; Huma | 1996 |
Creatine and phosphocreatine analogs: anticancer activity and enzymatic analysis.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Breast Neoplasms; Carcinoma; Cell Death; Colonic Neo | 1996 |
1H-magnetic resonance spectroscopic observation of cultured malignant cells pharmacologically induced to different phenotypes.
Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Butyrates; Butyric Acid; Cho | 1996 |
Proton (1H) MR spectroscopy for routine diagnostic evaluation of brain lesions.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Aged, 80 and over; Aspartic Acid; Brain Diseases; Brain Neo | 1997 |
Localized in vivo 1H nuclear MR spectroscopy for evaluation of human uterine cervical carcinoma.
Topics: Adenocarcinoma; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Choline; Creatine; Female; Human | 1998 |
Creatine and cyclocreatine treatment of human colon adenocarcinoma xenografts: 31P and 1H magnetic resonance spectroscopic studies.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Body Water; Cell Division; Colonic Neoplasms; Creati | 1999 |
Monitoring tumor growth and regression by 31P magnetic resonance spectroscopy.
Topics: Adenine Nucleotides; Adenocarcinoma; Animals; Cell Division; Creatine; Female; Magnetic Resonance Sp | 1990 |
Growth studies of subcutaneous rat tumours: comparison of 31P-NMR spectroscopy, acid extracts and histology.
Topics: Adenocarcinoma; Animals; Carcinoma 256, Walker; Cell Division; Creatine; Liver Neoplasms, Experiment | 1989 |